Hongkui Deng
邓宏魁
Hongkui Deng is a stem cell biologist and chief scientist at Beiqi Biotech (北启生物), a ZhenFund angel portfolio company he founded in 2022 to develop cell therapies based on chemically induced pluripotent stem cells (CiPSC) . He holds appointments as a Boya Chair Professor at Peking University and lead scientist at Changping Laboratory . His research pioneered the use of small molecules rather than transcription factors to reprogram somatic cells into pluripotent stem cells, work that earned him the 2024 Future Science Prize in Life Sciences . In November 2025 he was elected to the Chinese Academy of Sciences, and earlier that year TIME named him to its TIME100 Health list .
AI-generated — may contain errors, please verify.
Coverage
A Whole New World | Z News
We invite you to look back on the past month's "highlight reel" — a look at how our portfolio companies have grown and what's new at ZhenFund.
真格基金·Greener Pastures, First Flickers of Ambition | Z News
The light and shadow grow richer; a story is brewing.
真格基金·2024 Future Science Prize Winners Announced | Z News
Celebrating scientists and honoring the spirit of scientific inquiry.
真格基金·
